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Abstract
The induction of sensory organ placodes, in particular the lens placode, represents the paradigm for induction. We show that medaka Sox3
is expressed in the neuroectoderm and in the placodes of all sensory organs prior to placode formation and subsequently in placode-derived
tissues. Ectopic Sox3 expression leads to ectopic expression of Pax6 and Eya1 in embryonic ectoderm and causes ectopic lens and otic vesicle
formation. The descendants of cells ectopically expressing Sox3-mRNA contribute to ectopic lens tissue. This suggests a permissive role for
Sox3 in establishing a placodal competence. In addition, ectopic Sox3 expression leads to the dysgenesis of the endogenous sensory organs.
Both effects of ectopic Sox3 expression can be separated by ectopic expression of a truncated Sox3 variant depending on its expression level.
Our data suggests that Sox3 is a permissive factor for sensory placode formation and plays an important role in sensory organ development.
q 2000 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
The development of the sensory organs and in particular
the eye is a paradigm for induction during vertebrate devel-
opment (Spemann, 1901; Jacobson, 1966; Grainger, 1996).
Essential components of the nose, eye, and ear develop from
surface ectodermal derivatives, the sensory placodes, local
thickenings of the ectoderm that are the ®rst morphological
sign of ectodermal contributions to the forming vertebrate
sense organs (Webb and Noden, 1993). These placodes give
rise to the olfactory epithelium, the lens, the cranial ganglia,
and the inner ear, respectively. While the nasal and lens
placodes are located in the anterior ventral head ectoderm,
the otic placode originates more dorsally in the posterior
head ectoderm adjacent to the prospective rhombencepha-
lon.
All sensory placodes initially develop in a similar pattern,
as they invaginate into their surrounding tissue and in the
case of lens and otic vesicles subsequently delaminate to
form a separated vesicle. Tranplantation experiments and
recent genetic studies in amphibians and ®sh provide
evidence that sensory placode formation in the head ecto-
derm is induced by the neuroectoderm and cephalic mes-
endoderm during late gastrula and neurula stages. (Jacob-
son, 1966; Jacobson and Sater, 1988; Gallagher et al., 1996;
Grainger, 1996; Mendonsa and Riley, 1999).
So far, only a few molecules that are involved in sensory
placode development have been identi®ed. Among them are
the transcription factors Pax6 and Eya1. In Pax6 homozy-
gous mutant mice the formation of the nasal and lens
placodes does not occur leading to a subsequent loss of
the nasal pit, lens and entire eye (Hill et al., 1991; Grindley
et al., 1995). Loss of function mutations in a human homo-
logue of the Drosophila eyes absent gene (eya) lead to
defects or the loss of the placode-derived inner ear and are
the cause of deafness in the human Branchio-Oto-Renal
syndrome (Abdelhak et al., 1997).
Expression in all sensory placodes has been reported for
Sox2 and Sox3, during early stages of sensory placode
development in frog, chick, and mouse embryos (Uwanogho
et al., 1995; Collignon et al., 1996; Penzel et al., 1997;
Zygar et al., 1998). However, their function in embryonic
development remains elusive. SOX transcription factors
contain a highly conserved High Mobility Group (HMG)
domain (Laudet et al., 1993) which in the case of the
SOX1,2,3-subgroup is located in the N-terminus. Within
the SOX subfamily this domain binds to DNA with high
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af®nity in a sequence speci®c manner. In addition, in several
SOX family members a C-terminal transactivation domain
has been identi®ed, which, in the case of SOX2, has been
shown to activate the transcription of lens-speci®c crystallin
genes directly (Kamachi et al., 1995, 1998).
Functionally, SOX transcription factors have been impli-
cated in cell fate decisions during embryogenesis. Muta-
tions in the human SRY gene, the founding member of the
Sox transcription factor family, leads to sex reversal (Berta
et al., 1990; Koopman et al., 1990). Misexpression of Sry
in the mouse causes cells destined to become ovaries to
differentiate into testes (Koopman et al., 1991). Further-
more Sox1, a member of the Sox1,2,3-subgroup, when
ectopically expressed in P19 cells, which otherwise have
the potential to differentiate into cell types of all three germ
layers (McBurney, 1993), mediates P19 cells to differenti-
ate into neural cell types in vitro (Pevny et al., 1998). This
®nding together with the placodal expression of other Sox
family members (Uwanogho et al., 1995; Collignon et al.,
1996; Penzel et al., 1997; Zygar et al., 1998) suggests that
Sox genes are important for the proper development of the
placode-derived components of the sense organs.
Here we report the isolation of a Sox3 homologue from
the medaka ®sh (Oryzias latipes) which is expressed in the
entire neuroectoderm, in the presumptive placodal ectoderm
prior to placode formation and subsequently in all placodes
of the sensory organs. Ectopic Sox3 activity leads to the
ectopic expression of Pax6 and Eya1 in the embryonic ecto-
derm, consistent with ectopic formation of placode-derived
tissues. Ectopic Sox3 expression elicits the formation of
ectopic lenses and otic vesicles in the ectoderm of develop-
ing embryos. This suggests a permissive role for Sox3 as a
competence factor for neural and placode induction.
Ectopic expression of Sox3 also results in the dysgenesis
of the endogenous eye and ear. Ectopic expression of a
truncated variant of Sox3 containing the HMG DNA-bind-
ing domain allowed the experimental separation of ectopic
placode formation from the dysgenesis of the sensory
organs. At low doses the DNA-binding of the Sox3-HMG-
domain is suf®cient to elicit ectopic placode formation. At
higher doses however it results in eye and ear dysgenesis
which is likely to be caused by a dominant-negative effect of
ectopic Sox3 expression.
2. Results
2.1. Isolation of medaka Sox3
A cDNA-fragment of the medaka (Oryzias latipes) Sox3
homolog was ampli®ed by RT-PCR. This fragment was
subsequently used to screen a neurula stage cDNA library,
which lead to the isolation of a full-length (1786 bp) Sox3
cDNA. The deduced amino acid sequence (300 aa) shows
highest similarity to the Sox3 transcription factor from chick
(84% aa identity) and contains in its N-terminal region a
highly conserved DNA-binding HMG-domain of 79 aa.
This HMG-domain is most closely related to HMG-domains
of SOX3- and SOX2-homologues from other vertebrates
(95±91% aa identities, Fig. 1). At the C-terminus, the
ORF encodes another conserved domain, which has recently
been shown to act as transcriptional activator in other SOX
2,3 proteins (Kamachi et al., 1998). This C-terminal domain
of the medaka cDNA shows higher similarity to vertebrate
SOX3-proteins (67±56% aa-similarity) than to the respec-
tive SOX2 sequences (49±47% aa-similarity; Fig. 1). These
®ndings indicate that the isolated cDNA encodes the
medaka SOX3-protein.
2.2. Sox3 is expressed in the neuroectoderm and the
ectodermal placodes of the sensory organs during early
medaka embryogenesis
In situ hybridization detected Sox3 expression in the
entire ectoderm, elevated in the prospective head ectoderm
as well as in the marginal zone of the epiblast shortly after
the onset of gastrulation (50% epiboly), the earliest stage
analyzed (Fig. 2A). During subsequent stages Sox3 expres-
sion is found in the entire ectoderm (Fig. 2A±C) and persists
in the neuroectoderm along the entire body axis in the form-
ing and differentiating CNS (Fig. 2D±F) with the exception
of the ¯oorplate. During early somitogenesis, neural expres-
sion of Sox3 is downregulated in the outbudding optic vesi-
cle. At late organogenesis stages, Sox3 expression in the
central nervous system (CNS) becomes restricted to the
germinal zones (not shown).
Outside the developing CNS Sox3 is initially expressed
throughout the entire ectoderm at neurula stages. Two bilat-
eral domains of elevated Sox3 expression in the surface
ectoderm laterally ¯ank the CNS at the level of the prospec-
tive rhombencephalon (Fig. 2C, arrows) and become subse-
quently more con®ned (Fig. 2D,E, arrowheads). This
expression persists until the onset of somitogenesis. At
this stage Sox3 is expressed in the ectoderm opposing the
forming optic vesicle (Fig. 2E) and the nasal pit (Fig. 2E,F).
Sox3 expression, which is initially distributed over the entire
anterior head ectoderm, progressively becomes con®ned to
the nasal pit, the lens vesicle, and distinct cells in the rhom-
bencephalic ectoderm (Fig. 2F) forming the otic placode.
Sox3 expression in the ectodermally derived tissues of the
sense organs persists until organogenesis and is detected in
the olfactory epithelium (Fig. 2G, arrowheads), the differ-
entiating lens (Fig. 2H), and inner ear (Fig. 2I).
Expression in tissues of the forming sensory placodes is
in good accordance with the expression reported for mouse
and chick Sox3 homologues (Uwanogho et al., 1995;
Collignon et al., 1996). Expression relates well to the one
reported for Xenopus by Penzel et al. (1997), which is in
con¯ict to the data reported by Zygar et al. (1998) during
lens bias and speci®cation period.
As an independent marker for placodal tissue we
employed the medaka eyes absent 1 (Eya1) gene. Homolo-
R.W. KoÈster et al. / Mechanisms of Development 95 (2000) 175±187176



























































































































































































R.W. KoÈster et al. / Mechanisms of Development 95 (2000) 175±187178
Fig. 2. Expression of Sox3 during medaka embryonic development. During gastrulation (A, st. 15) expression covers entire ectoderm and is elevated in
neuroectoderm during subsequent stages of neurulation (B st. 16; C st. 17). Note stronger expression in epithelial ectoderm of rhombenecephalic region
(arrows). Expression in CNS persists during somitogenesis (D st. 19, E st. 21; F st. 24). Ectodermal expression becomes con®ned to cells juxtaposed to sensory
organs (D±F arrowheads). Expression is found in nasal pit (F; G st. 27 organogenesis, arrowheads), lens vesicle (F), differentiating lens (H st. 27 organogen-
esis), and inner ear (I st. 34 organogenesis). Transverse section of whole-mount stained embryo (E, inset). In rhombencephalic ectoderm Sox3 expression is
con®ned to otic vesicle and lateral line structures (arrowheads). (J st.22). Rhombencephalic region of a double stained embryo, Pax2 in blue, Sox3 in red. Pax2-
expression demarcates mid-hindbrain boundary and otic vesicles; Sox3 expression in rhombencephalic ectoderm is juxtaposed to Pax2 in otic vesicles. (K st.
19) Dorsal view of head region of a double stained embryo, Pax2 blue, Eya1 red. During onset of somitogenesis medaka Eya1 expression is con®ned to anterior
head ectoderm (arrowhead), anterior to the prospective lens placode and the Sox3-expressing region (compare D) in lateral rhombencephalic ectoderm
(arrowhead). ec, ectoderm; hec, head ectoderm; lp, lens placode; lv, lens vesicle; mes, mesencephalon; mhb, mid-hindbrain boundary; mz, marginal zone;
nec, neuroectoderm; np, nasal placode; otv, otic vesicle; ov, optic vesicle; pros, prosencephalon; rh, rhombencephalon; y, yolk.
gues of the Drosophila gene eyes absent (eya) gene have
been cloned from mice and are expressed in an overlapping
manner in all cranial placodes (Xu et al., 1997). A PCR-
cloned medaka Eya-fragment of 762 bp (see methods) was
used to screen a neurula stage cDNA-library. Several partial
cDNAs were isolated, the longest of which is 2071 bp in
length. Sequence analysis revealed that this cDNA contains
an ORF encoding a putative protein with a C-terminal EYA-
domain, a highly conserved region of 271 amino acids. The
isolated medaka EYA-domain shows the highest homology
to the human (95.2% aa identity) and mouse (93.7% aa
identity) EYA1 homologues, identifying the isolated
cDNA as a medaka Eya1 homologue. During early somito-
genesis, Eya1 expression is found in the anterior-most head
ectoderm (Fig. 2K, note that Eya1 expression is excluded
from the prospective lens placode region) and subsequently
in the nasal placode (data not shown). In addition, Eya1
expression in a longitudinal thickening of the rhombence-
phalic ectoderm demarcates the otic placode Fig. 2K). Later
it is expressed in the otic vesicle (data not shown). The
overlapping expression pattern of medaka Eya1 and Sox3
in the posterior head ectoderm indicates that the Sox3
expressing cells in the rhombencephalic head ectoderm
belong to the otic placode (compare Fig. 2J,K). During
organogenesis medaka Eya1 is expressed in the olfactory
epithelium (Fig. 3D) and the inner ear, derivatives of the
nasal and otic placodes (Fig. 6D) but not in the lens (Fig.
3D).
2.3. Misexpression of Sox3 results in ectopic ectodermal
activation of Pax6 and Eya1
Sox3 is expressed in the presumptive sensory placodal
ectoderm and becomes re®ned to the sensory placodes and
their derivatives. To investigate whether ectopic Sox3
effects the expression of placode marker genes we analyzed
the expression of Pax6and Eya1. Pax6 is expressed in the
nasal and lens placodes (Grindley et al., 1995; Loosli et al.,
1998). As a marker for the nasal and the otic placode we
analyzed Eya1 expression.
Sox3-mRNA was injected into a single blastomere at the
two-cell stage and embryos were analyzed for Pax6 expres-
sion by whole-mount in situ hybridization after 2 days of
development (st. 27), prior to the stage when ectopic
placode-derived tissue becomes morphologically obvious
(see below). Ectopic Pax6 expression in the ectoderm was
detected at a frequency of 12.1% (16/132, Table 1). In
detail, ectopic expression of Pax6 was found in the lateral
and ventral head ectoderm, mainly between the lens and the
otic vesicle (Fig. 3B, arrowhead). Less frequently we
detected ectopic Pax6 expression in the anterior ectoderm
between the nasal pits (Fig. 3C, arrowhead), and rarely in
lateral head ectoderm posterior to the otic vesicle (not
shown). However, cells ectopically expressing Pax6 were
never found in dorsal head ectoderm or the ectoderm ¯ank-
ing the trunk.
Eya1 is also ectopically expressed in the ectoderm of
Sox3-injected embryos at a frequency of 16.7% (25/125,
Table 1). Ectopic Eya1 expression is observed in the ante-
rior head ectoderm that joins the two nasal pits which are
normally separated by anterior non-Eya1-expressing head
ectoderm (Fig. 3D,E). Ectopic expression of Eya1 is also
activated in the dorsal head ectoderm (Fig. 3F,G) as well as
in dorsal (Fig. 3H,I) and lateral (not shown) trunk ectoderm.
In some cases, cells ectopically expressing Eya1invaginate
into the underlying neuroectoderm (Fig. 3I, arrowhead). In
control-injected embryos ectopic expression of Pax6 (0/
156, Table 1; Fig. 3A) or Eya1 (0/167, Table 1; Fig.
3D,F) was not observed.
2.4. Ectopic Sox3 activity leads to ectopic lens and otic
vesicle formation in the ectoderm
As ectopic expression of Sox3 resulted in the ectopic
expression of the early placodal markers Pax6 and Eya1
we next asked whether ectopic Sox3 expression leads to
the ectopic formation of differentiating placodal tissues.
After 3 days of development (st. 34, organogenesis) Sox3-
injected embryos displayed the formation of lens-like and
otic vesicle-like structures at ectopic locations in the
embryonic ectoderm. Ectopic lens-like structures are
surrounded by an epithelium and were found in the lateral
and ventral head ectoderm (24/255, Table 1; Figs. 3B,C and
4B, arrowhead). Ectopic expression of Sox3 also resulted in
the formation of vesicular structures resembling otic vesi-
cles by morphological criteria (8/289, Table 1). These vesi-
cles were located in the dorso-lateral trunk ectoderm
adjacent to the neural tube (Fig. 4C, arrowhead).
To unambiguously identify the ectopic structures as lenses
and otic vesicles Sox3-injected embryos were analyzed using
tissue speci®c markers. All of the Sox3-injected embryos,
which displayed ectopic spherical structures (9,4%, 24/255,
Table 1), expressed the lens ®ber speci®c a-crystalline gene
ectopically (Fig. 4B). This indicates that the ectopic expres-
sion of Sox3 leads to the formation of differentiating lenses at
ectopic locations in the ectoderm. The ectopic lenses formed
exclusively in the lateral (Fig. 4B) and ventral head ectoderm
(data not shown) and were not observed in the dorsal head or
trunk ectoderm. Thus, the frequency and location of the
forming ectopic lenses is consistent with the restriction of
ectopic Pax6 expression to these domains. It is noteworthy
that ectopic lenses never replaced endogenous placode-
derived tissues such as the nasal pit or the otic vesicle. In
control-injected embryos neither ectopic lens-like structures
nor cells ectopically expressing a-crystalline were observed
(0/255, Table 1) indicating that ectopic lens formation is a
speci®c result of ectopic Sox3 expression.
For the analysis of the ectopic vesicles we used Eya1 and
Pax2 as markers which, in wild-type embryos, are coex-
pressed only in the ear (Fig. 2J,K). Morphologically visible
ectopic vesicles in the posterior lateral ectoderm form in
2.8% (8/289, Table 1) of the Sox3-mRNA injected embryos.
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Double in situ analysis revealed that Pax2 and Eya1, as in
normal otic vesicles, are coexpressed in these structures
(Fig. 4C, inset). This shows that ectopic Sox3 activity in
addition to ectopic lens formation can also result in the
formation of ectopic otic vesicles. In control-injected
embryos the formation of ectopic otic vesicles was never
found (0/335, Table 1).
2.5. Descendants of Sox3-injected blastomeres contribute to
the ectopic lenses
With respect to ectopic lens formation ectopic Sox3 can
either act in the inducing or induction signal receiving
tissue. In the former case descendants of the Sox3-injected
blastomere will not contribute to ectopic lens tissue while
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Fig. 3. Ectopic expression of Pax6 and Eya1 in the head ectoderm of Sox3-mRNA injected medaka embryos. (A±C) Dorsal views of embryos (st. 27) stained
for Pax6 expression. (A) Control-injected embryo, note endogenous Pax6-expression in nasal pits. Ectopic expression of Pax6 in Sox3-injected embryos
located in lateral head ectoderm (B) posterior between eye and otic vesicle or in anterior head ectoderm between nasal pits (C) forming a spherical structure
(lateral view in inset). (D±G) Dorsal view of head, (H±I) lateral views of trunk of embryos stained for Eya1 expression. (D,F) Control-injected embryos, (D)
endogenous Eya1 expression restricted to nasal pits, (F) no Eya1 expression is found in dorsal head ectoderm or (H) trunk ectoderm. Note that Eya1 trunk
expression is con®ned to somites. In Sox3-injected embryos ectopic expression of Eya1 is found (E) in anterior head ectoderm joining nasal pits or (G) further
dorsally in dorsal telencephalic ectoderm. (I) Trunk cells ectopically expressing Eya1 form invaginating structures (arrowhead) in dorsal ectoderm overlying
neural tube. l, lens; np, nasal pit; otv, otic vesicle; tel, telencephalon.
they will do so in the latter. To address if cells, which
express Sox3 ectopically, contribute to the forming ectopic
lenses we coinjected Sox3- and lacZ-mRNA encoding a
nuclear-b-galactosidase into single blastomeres of 8-cell-
stage medaka embryos. The injected embryos were stained
for b-galactosidase activity after 2 days of development.
Subsequently the expression of a-crystalline was analyzed
by whole-mount in situ hybridization using the ¯uorescent
substrate FastRed. In the ectopic lenses formed in response
to Sox3-injection b-gal activity is detected, which partially
overlaps with a-crystalline expression (Fig. 5A,B). This
demonstrates that descendants of the initially injected blas-
tomere are not excluded from the ectopic lenses, but do
contribute to these ectopic tissues. This suggests that ectopic
Sox3 expression renders ectodermal cells competent to
respond to placode inducing factors. Outside of placodal
tissue lacZ-expressing cells were also found in the surface
ectoderm. This hints at a permissive role for Sox3 in the
establishment of a placodal identity in embryonic ectoder-
mal cells.
2.6. Ectopic Sox3 expression results in dysgenesis of
endogenous sensory organs
Ectopic expression of Sox3 results besides ectopic lens
and otic vesicle formation in a second morphological effect,
the dysgenesis of the endogenous sensory organs. Injected
embryos show a reduction (Fig. 6B, arrowhead) or loss (Fig.
6C) of endogenous eyes (61/255, Table 1). This abnormal
eye development is already obvious at the onset of somito-
genesis by a diminished or even absent evagination of the
optic vesicles from the lateral walls of the neural tube, a
developmental stage when the optic vesicles normally still
express Sox3 in wild-type embryos (compare Fig. 2D).
Similar to the dysgenesis of the eyes in a number of the
injected embryos (32/262, Table 1; Fig. 6D), otic vesicles
were reduced in size or even lost. This indicates that for
proper development of the optic and otic vesicle the total
level of Sox3 expression is critical. In control-injected
embryos the eye (0/292, Table 1) or otic vesicle (0/335,
Table 1) developed normally, demonstrating that the
dysgenesis of the sense organs is speci®cally due to the
ectopic expression of the Sox3.
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Fig. 4. Ectopic expression of Sox3 leads to the formation of ectopic lenses
and otic vesicles in the embryonic ectoderm. (A,B) Whole-mount in situ
hybridization for a-crystallinexpression. (A) Control-injected embryos,
expression of a-crystallin is con®ned to the lens. (B) Sox3-injected embryo
with ectopic lens (arrowhead) located in lateral head ectoderm between
endogenous lens and otic vesicle. Note spherical shape of a-crystallin posi-
tive tissue, identifying lens-®ber cells. Like endogenous lens, ectopic lens is
surrounded by lens epithelium. (C) Sox3-injected embryo stained for Pax2-
(blue) and Eya1-expression (red). An ectopic otic vesicle (arrowhead)
expressing both Pax2 and Eya1 (see inset) located in dorso-lateral ectoderm
of the trunk adjacent to neural tube. l, lens; lep, lens epithelium; ot, optic
tectum; otv, otic vesicle; rh, rhombencephalon.
Table 1
Effects of ectopic Sox3-mRNA expression
Sox3-mRNA (30 ng/ml) gfp-mRNA (30 ng/ml)
Affected no. (%) Total no. Affected no. (%) Total no.
Ectopic Pax6 (st. 27) 16 (12.1) 132 0 (0) 156
Ectopic Eya (st. 27) 25 (16.7) 125 0 (0) 167
Ectopic lenses (st. 34) 24 (9.4) 255 0 (0) 292
Lens split in eyecup (st. 34) 24 (9.4) 255 6 (2.1) 292
Ectopic otic vesicles (st. 34) 8 (2.8) 289 0 (0) 355
Reduced or lost eye (st. 34) 61 (23.9) 255 0 (0) 292
Reduced or lost otic vesicle (st. 34) 32 (12.2) 262 0 (0) 355
2.7. The Sox3 HMG-domain phenocopies the effects of
ectopic Sox3 expression
To investigate whether the formation of ectopic placodal
tissue and the dysgenesis of sensory organs observed upon
ectopic Sox3 expression can be mimicked by one of the two
known functional domains of Sox3, we generated a trun-
cated variant of medaka Sox3, Sox3D. This encodes the
DNA-binding HMG-domain and a part of the linker region,
but not the transactivation domain (Figs. 1 and 7A). Dose-
response analysis by mRNA injection into two-cell-stage
embryos showed that the frequency of ectopic lens forma-
tion increases with raising mRNA-concentration and peaks
at 175 ng/ml (20/137, Table 2). At this concentration ectopic
lenses formed in 14.6% of the injected embryos (Fig. 7B;
20/137, Table 2). However, only 2.2% of the embryos
showed reduced eyes (3/137, Table 2). Further increase of
the Sox3D-mRNA concentration to 250 and 320 ng/ml,
respectively, leads to a drop in the frequency of ectopic
lens formation to 2±5% (Table 2). At these concentrations
eye dysgenesis appears in 20.4% of the injected embryos
(28/137, Table 2; Fig 7C). In control-injections using GFP-
mRNA, neither ectopic lens formation nor dysgenesis of the
eyes was observed, demonstrating that the effects are speci-
®c for ectopic expression of Sox3D (Table 2).
Thus in ectopic expression studies the HMG-DNA-bind-
ing-domain is suf®cient to elicit both effects obtained with
full length Sox3 in a concentration dependent manner.
While ectopic lens formation peaks at lower concentrations
the dysgenesis of the eye requires higher effective Sox3D
concentrations (Fig. 7D). This hints at a dominant negative
role for Sox3D under these conditions causing the dysgen-
esis of sensory organs, which express Sox3 endogenously.
3. Discussion
3.1. Medaka Sox3 is a candidate for rendering ectodermal
cells competent to differentiate into placode-derived tissues
Induction processes play a critical role during placode
development. Competence factors act in the induction
signal receiving tissue in a permissive manner to enable a
cell to become induced and to subsequently contribute to a
distinct tissue.
We have isolated a medaka homologue of the Sox3 gene,
which during gastrulation is initially expressed ubiquitously
in the ectoderm. Subsequently, Sox3 expression becomes
restricted to the neuroectoderm and placodes of the sensory
organs and persists in the placode-derived differentiating
tissues. Thus, the endogenous spatio-temporal expression
of Sox3 matches the dynamic competence for sensory
placode formation in the ectoderm as described by trans-
plantation analysis in amphibians (Jacobson, 1963; Grain-
ger, 1992; Gallagher et al., 1996). Sox3-expression is
already observed at the onset of gastrulation and thus
precedes the expression of lens-inducing signals during
late gastrulation stages (Grainger, 1992). Expression of
Sox3 in the head ectoderm already during early gastrulation
indicates that SOX3 acts prior to lens induction in the ecto-
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Fig. 5. Descendants of the Sox3-injected blastomere participate in ectopic lens formation. (A,B) Ventral head view of an embryo by (A) transmission and (B)
¯uorescent microscopy. (A) Cells ectopically expressing a-crystallin (red) show colocalization (arrowhead) of b-galactosidase-(blue). (B) Cytoplasmic
FastRed-emission due to a-crystallin expression is quenched in the same cell by b-galactosidase-activity in and around its nucleus.
derm and makes it unlikely that Sox3-expression is a
response of ectodermal cells having already received a
lens-inducing signal. Thus, the endogenous expression of
Sox3 is consistent with SOX3 being involved in the estab-
lishment of a placodal competence in the ectoderm rather
than in transducing lens inducing signals inside prospective
placodal cells.
If Sox3 expression in the ectoderm permits sensory
placode formation, genes expressed in these placodes
should be activated ectopically in mRNA injection experi-
ments. In wild-type embryos surface ectodermal expression
of Pax6 (nasal and lens placode) and Eya1 (nasal and otic
placode) is observed in the sensory placodes. In Sox3
injected embryos expression of both Pax6 and Eya1 was
detected at ectopic locations in the ectoderm. This suggests
that ectopic placodal cells are generated upon ectopic Sox3
activity. As these ectopic placodes arise in a locally
restricted manner and not over the entire ectoderm (see
also below) suggests that other factors in addition to
SOX3 are involved in establishing a placodal competence.
The formation of ectopic lenses and ectopic otic vesicles in
Sox3 injected embryos indicates that ectopic expression of
Sox3 in the ectoderm not only leads to the ectopic expres-
sion of early placodal genes but also permits ectodermal
cells to differentiate into placode-derived structures. Since
descendants from lacZ- and Sox3-mRNA coinjected cells
were found inside the ectopically formed lenses and were
not excluded from the endogenous or ectopic placode-
derived tissues, Sox3 functions inside the induced tissue,
the endogenous or ectopic placode. The proposed permis-
sive role for Sox3 in ectopic placode formation is consistent
with the ®nding that not all b-galactosidase expressing
descendants from the Sox3 injected blastomere were located
in placode-derived tissues. These cells, although competent
for placodal fates may have missed respective inductive
signals.
Sox3 expression in placodal tissues might not only be
involved in mediating a placodal competence. Endogenous
expression of Sox3 in the placode derived tissues long after
placode formation rather suggests that Sox3 is also involved
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Fig. 6. Ectopic expression of Sox3 results in the dysgenesis of the endogenous eye and otic vesicle. (A±C) Ventral head views of 3 days old embryos stained for
a-crystallin expression. In (A) control-injected embryos dysgenesis of eyes was not observed while (B, arrowhead) Sox3-mRNA injected embryos display
signi®cant size reduction (C, arrowhead) or complete loss of the eye on the injected side. (D) Dorsal view of rhombencephalic region of a Sox3-mRNA injected
embryo stained for Eya1 expression. Otic vesicle (arrowhead) is lost on one side while staining in adjacent lateral line is still observed.
in later steps of placode differentiation. The frequency of
ectopic placode formation of 12 (ectopic Pax6 expression)
to 16% (ectopic Eya1 expression, see Table 1) in the
injected embryos may re¯ect this later requirement that
can not be achieved by mRNA injections.
3.2. Ectopic Sox3 might mediate a principal placodal
competence that is further speci®ed by regionalizing factors
The nasal epithelium, lens, and otic vesicle seem to be
induced by similar mechanisms during the early phases of
their development. Such a general placodal ground state is
evident through the similarity of the sequential inductive
processes of lens and otic vesicle formation as revealed by
transplantation experiments in Xenopus laevis embryos
(Jacobson, 1966; Gallagher et al., 1996).
During gastrulation of amphibian embryos initially the
entire ectoderm is competent to develop into a lens (Jacob-
son, 1966; Grainger, 1992) or an otic vesicle. For the lens
this capacity is subsequently restricted to the lateral and
ventral head ectoderm of amphibian and chick embryos
and is lost in other ectodermal cells (Jacobson, 1966; Bara-
banov and Fedtsova, 1982; Grainger, 1992) while the
posterior head ectoderm becomes biased to form the otic
placode (Gallagher et al., 1996). Subsequently as develop-
ment proceeds the placodes get further speci®ed by the
distinct local cellular environment (Jacobson, 1963).
In wild-type embryos surface ectodermal expression of
Pax6 is found in the nasal and lens placodes while Eya1 is
detected in the nasal and otic placodes. The spatial restric-
tion of both ectopic Pax6-expression and successive forma-
tion of ectopic lenses exclusively in the ventro-lateral head
ectoderm in Sox3-mRNA-injected medaka embryos is in
accordance with these classical competence studies. The
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Fig. 7. Ectopic expression of the N-terminal HMG-containing part of medaka Sox3 leads to ectopic lens formation and eye degeneration in a concentration
dependent manner. (A) Schematic representation of wt and truncated version of Sox3 ectopically expressed in medaka embryos. (B) Injected embryo stained
for a-crystallin expression showing formation of an ectopic lens in lateral head ectoderm (arrowhead). (C) Ventral view of injected embryo stained for a-
crystallin expression, demonstrating eye loss (arrowhead) upon ectopic expression of high doses of Sox3D. (D) Dose response curve for Sox3D. Eye dysgenesis
needs higher concentrations than ectopic placode formation and is steadily increasing until severe gastrulation defects followed by lethality are predominant
(see also text and Table 2).
®nding of ectopic Eya1 expression upon ectopic Sox3-
expression in cells of the posterior and dorsal head- and
trunk-ectoderm is consistent with the more dorsal origin
of the otic placode. Accordingly, ectopic otic vesicles
were located exclusively in the dorso-lateral part of the
head ectoderm posterior to the ectopic lenses and in the
dorso-lateral ectoderm ¯anking the trunk. We therefore
suggest that Sox3 confers to ectodermal cells a principal
placodal competence. Upon the activity of regionalizing
factors the forming ectopic placodes adopt a distinct identity
(nasal, lens, otic) according to their position in the ecto-
derm. As shown previously, ectopic expression of Six3 by
DNA injection in medaka is capable of inducing ectopic
lenses close to the otic vesicle or replacing the otic vesicle
with a lens (Oliver et al., 1996). Sox3 RNA-injection
however did not result in ectopic expression of Six3 in the
ectoderm (data not shown). The surprising ®nding that ecto-
pic otic vesicles also form in the trunk ectoderm shows that
in principle also in the trunk otic placode induction can
occur once ectodermal cells have been rendered competent
to respond to these factors due to ectopic Sox3 expression.
Whether also ectopic nasal placodes were generated in
Sox3-mRNA injected embryos can only be addressed indir-
ectly due to the lack of appropriate nasal-speci®c marker
genes in medaka. However, ectopic overlapping expression
of Pax6 and Eya1 in the anterior head ectoderm (compare
Fig. 3C,E) argues for ectopic nasal placode formation as the
nasal placode is the only ectodermal tissue, in which these
two genes are coexpressed.
3.3. Ectopic expression of the Sox3-HMG-domain alone
allows separation of ectopic placode formation from
sensory organ dysgenesis
The SOX3 protein contains two main functional domains,
the DNA-binding HMG-domain in its N-terminus and a
transcriptional activation domain, which is located in the
C-terminus. Separating these two domains leads to a separa-
tion of the two effects observed in ectopic Sox3 expression
studies, namely ectopic placode formation and sensory
organ dysgenesis. Lower amounts of the N-terminal
HMG-containing domain (Sox3D) lacking also most of the
linker region between these two domains (see Fig. 1)
resulted in the ectopic formation of lenses and otic vesicles
without sensory organ dysgenesis. With rising mRNA
concentrations of Sox3D, dysgenesis of the sensory organs
increases and eventually leads to lethality of the injected
embryos. This shows that Sox3D can functionally replace
wild-type Sox3 in a concentration dependent manner.
Dose response analysis using Sox3D shows that ectopic
placode formation is a consequence of low-level, Sox3D
expression. A dominant-negative function was demon-
strated in detail for an analogously truncated version of
Sox2 (Johnson et al., 1998). Consequently, at higher expres-
sion levels, endogenous Sox3 function is affected dominant-
negatively resulting in the dysgenesis of the endogenous
sensory organs. In mouse the phenotypes obtained after
inactivation of Sox1 (Nishiguchi et al., 1998) are similar
to the injection of high amounts of Sox3D further substan-
tiating the suggested dominant negative activity of Sox3D at
high concentrations. Wild-type Sox3-mRNA very potently
leads to both morphological effects, ectopic placode forma-
tion and sensory organ dysgenesis already at minute concen-
trations not allowing a dose response analysis. The results
obtained with Sox3D suggest that wild-type Sox3 already at
lowest concentrations acts in a dominant-negative way in
the endogenous Sox3 expression domains resulting in
sensory organ dysgenesis while at ectopic locations ectopic
placodes are elicited as a gain of Sox3-function at the same
time.
How can wild-type Sox3 and Sox3D mediate combinator-
ial effects of gain and loss of function when expressed ecto-
pically? HMG-domain transcription factors, and also SOX2
the closest paralogue of SOX3, form ternary complexes with
transcriptional activators and DNA (Kamachi and Kondoh,
1993; Zwilling et al., 1995; Behrens et al., 1996; Zappa-
vigna et al., 1996; Kuhlbrodt et al., 1998; Kamachi et al.,
1999). This protein-protein interaction together with the
DNA-binding of each of the partners is essential for syner-
gistic transcriptional activation. On its own, the Sox2 DNA-
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Table 2
Effects of Sox3D mRNA-injection
Concentration of injected Sox3D -mRNA (ng/ml) Ectopic lens no. (%) Eye dysgenesis no. (%) Dead dead no. (%)
30 n.d. 0/148 (0.0) n.d.
100 n.d. 0/143 (0.0) n.d.
150 14/163 (8.6) 3/163 (1.8) n.d.
175 20/137 (14.6) 3/137 (2.2) n.d.
250 4/144 (2.8) 8/144 (5.6) n.d.
320 7/137 (5.1) 28/137 (20.4) 38/137 (27.7)
400 5/156 (3.2) 26/156 (16.7) 73/156 (46.8)
Concentration of injected gfp-mRNA (ng/ml)
150 n.d. 0/162 (0.0) n.d.
250 0/130 (0.0) 0/130 (0.0) n.d.
1000 n.d. 0/98 (0.0) 5/98 (5.1)
binding domain is incapable of transcriptional activation
(Ambrosetti et al., 1997; Kuhlbrodt et al., 1998; Kamachi
et al., 1999). However, for ternary complex formation the
HMG domain alone is suf®cient (Kamachi et al., 1999). The
interface of the protein-protein interaction comprises the
conserved (Fig. 1) DNA-binding HMG-domain and the
linker region between the HMG and transactivation
domains. Our ®ndings suggest that low ectopic Sox3D
expression similar to the expression of its full-length form
mediates the recruitment of Sox3-binding transactivators to
their common target sites. Subsequent transcriptional acti-
vation mediated by the transactivator results in the genera-
tion of an ectopic placodal competence and eventually leads
to ectopic placode formation. However, high ectopic
concentrations of Sox3D will force protein-protein interac-
tions interfering with the balance of SOX3-heterodimer and
ternary complex formation. We suggest that this disturbed
ternary complex eventually results in the loss of transcrip-
tional activation of Sox3 target genes causing the observed
dominant negative effect and endogenous sensory organ
dysgenesis. As wild-type Sox3 contains the entire linker
region its binding ef®ciency to co-transactivators should
be ef®cient (at least 5±6-fold in analogy to Sox2, Kamachi
et al. 1999)) and result in a dominant-negative effect already
at minute ectopic concentrations not clearly separable from
the gain of function concentrations by performing mRNA-
injections.
4. Materials and methods
4.1. Fish maintenance
Wild-type Oryzias latipes from a closed stock at the MPI
of Biophysical Chemistry were kept as described (KoÈster et
al., 1997). Staging of the embryos was performed according
to Iwamatsu (1994).
4.2. Isolation of medaka Sox3 and Eya1
A 671-bp Sox3-fragment was ampli®ed by RT-PCR from
total RNA isolated from the prospective head region of
neurula stage embryos (st. 17) using degenerate primers
speci®c for the Sox1,2,3subgroup (5 0-AARMGICCIAT-
GAAYGCITTYATG, 3 0- TACATISWIATCATRTCICK-
IARRTCICC). PCR-conditions were: 5 cycles 948C, 1
min; 458C, 2 min; 728C, 4 min; 30 cycles 948C, 1 min;
508C, 2 min; 728C, 4 min. The resulting PCR-product was
cloned into pCRII (Invitrogen), sequenced and used to
screen a late neurula medaka lZAP cDNA library at high
stringency. Positive phages were plaque puri®ed, converted
into Bluescript SK and sequenced (EMBL accession#:
AJ245396)
A 762 bp long Eya1 fragment was ampli®ed by PCR from
medaka genomic DNA using degenerate primers designed
on the basis of highly sequence conserved regions within the
EYA domains of Drosophila eyes absent and mouse Eya
genes (upper primer GTGTTMSTCTGGGAYCTGGAC-
GAGAC and lower primer GTGRSYGGAGA YSCKCCA-
GAAGG). PCR conditions were: 4 min, 948C; 5 cycles: 1
min, 948C, 2 min, 488C, 2 min, 728C; 35 cycles: 1 min,
948C, 2 min, 538C, 2 min, 728C. The resulting PCR product
was cloned into pCRII, sequenced and used to screen a
neurula stage lZAP cDNA library under high stringency.
Positive phages were puri®ed, converted into Bluescript SK,
and sequenced (EMBL accession#: AJ245395).
4.3. Whole-mount in situ hybridization, sectioning and b-
galactosidase activity staining
Whole-mount in situ hybridization and sectioning of
stained embryos was performed as described (KoÈster et
al., 1997) with the modi®cation of an increased temperature
of 658C in all hybridization and washing steps. In all double
labelings the NBT/BCIP (blue) staining was performed ®rst,
followed by the FastRed detection (red). Staining for b-
galactosidase was performed prior to whole-mount in situ
hybridization as described (Joore et al., 1996).
4.4. RNA injections
The open reading frame of the Sox3-cDNA DraI/AvrII
fragment (1052 bp) was subcloned into pCS21 (Rupp et
al., 1994). Sox3D (391 bp) was generated by DraI/NarI-
digestion of the Sox3-cDNA and subcloning into pCS21.
Capped RNA for injections was transcribed from linearized
vectors using the SP6 mMESSAGE mMACHINE Kit
(Ambion). Individual blastomeres of 2±16-cell stage
embryos were injected as described (KoÈster et al., 1997)
After initial injections of different dilutions (10, 30, 50
and 100 ng/ml) the concentration of Sox3-mRNA and gfp-
mRNA for controls was 30 ng/ml. For coinjections capped
mRNA encoding nuclear b -galactosidase was transcribed
from pCSnbgal (Rupp et al., 1994) and added to the injec-
tion solution at a concentration of 100 ng/ml.
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